MENU
IMMP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Immutep (IMMP) Ownership - Who owns Immutep?
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
264 George Street
Phone
+61 283157003
Employees
24
Web
https://www.immutep.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
240.7M
P/E Ratio
N/A
Total Cash
159.26M
Projected Growth
N/A
Total Debt
1.68M
Revenue
N/A
Risk (Beta)
1.88
Dividend Yield
N/A
Total Cash/Share
1.09
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
IMMP
Capitalization
241M
P/E Ratio
N/A
Risk (Beta)
1.88
Dividend Yield
N/A
Total Cash
159M
Total Cash/Share
1.09
Total Debt
1.69M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
172M
P/B Ratio
2.26
Cash Flow
N/A
Earnings
-0.33
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
543M
Current Ratio
18.86
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-43.83M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-28.66
Shares Held By Institutions
8.56M
Shares Outstanding - Current
146M
Total Liabilities
9.86M
Total Volume MTD
N/A
Value
-1
Gain YTD
-18.433
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of anti-cancer therapeutics
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
264 George Street
Phone
+61 283157003
Employees
24
Web
https://www.immutep.com